European Society for Medical Oncology/LinkedIn
Jun 9, 2025, 07:45
Register today for ESMO Immuno-Oncology Annual Congress – European Society for Medical Oncology
ESMO – European Society for Medical Oncology shared a post on LinkedIn:
“ESMOImmuno25: Check the programme and register today!
Connect with global experts in cancer treatment and research and explore innovative therapies that are shaping the future of oncology care.
Early registration deadline 8 October 2025.
Learning objectives:
-
Access immersion sessions in immunobiology and immuno-oncology translational research insights;
-
Review state of the art, checkpoint inhibitor-based therapeutic strategies in immuno-oncology;
-
Understand recent developments in immune modulation, including tumour: microenvironment, immunometabolism, epigenetics and cell signalling;
-
Connect with Industry and independent investigators for an overview of research and development in immuno-oncology, including cellular therapies, vaccines and immune modulators, intratumoural immunotherapy and multispecific constructs.”
ESMO announced key themes and learning objectives for ESMO Immuno 2025, with a focus on translational research, immune modulation, checkpoint strategies, and collaborative networking. Early registration closes on 8 October 2025.
More posts featuring European Society for Medical Oncology.
cancer
cell signalling
Cnacer Treatment
epigenetics
ESMO
ESMO Immuno-Oncology Annual Congress
ESMOImmuno25
European Society for Medical Oncology
fight against cancer
Global fight against cancer
immune modulators
immunobiology
Immunometabolism
intratumoural immunotherapy
microenvironment
OncoDaily
Oncology
Oncology care
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 9, 2025, 05:26
Jun 9, 2025, 05:19
Jun 9, 2025, 04:15